Trial Profile
Clinical Trials Insight: 700018498
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Nov 2006
Price :
$35
*
At a glance
- Drugs Ozarelix (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors AEterna Zentaris Inc; Spectrum Pharmaceuticals
- 16 Nov 2006 New trial record.